April 16, 2021
Sentynl Therapeutics, Inc. v. U.S. Specialty Insurance Co
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 09, 2022
Drugmaker's Opioid Probe Costs Not Covered, 9th Circ. Says
U.S. Specialty Insurance Co. has no obligation to cover more than $4 million in costs an opioid drugmaker said it incurred while responding to a U.S. Department of Justice investigation, the Ninth Circuit affirmed on Wednesday, citing a broad exclusion for claims relating to the company's products.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login